9

VanEck Genomics and Healthcare Innovators UCITS ETF
Orderdjup
Allmän information
- Årlig avgift0,35%
- TillgångsklassAktier
- KategoriBranschfond, läkemedel
- BasvalutaEUR
- UtdelningspolicyÅterinvesterande
- Faktablad
The Fund’s investment objective is to replicate the price and the performance, before fees and expenses, of an index that provides exposure to the performance of a representative portfolio of companies involved in the genomic healthcare and electronic healthcare industries.
Relaterade ETF:er
Exponering
Fördelning
- Aktier100%
Kunder har även besökt
Forum
Nyheter
Allmän information
- Årlig avgift0,35%
- TillgångsklassAktier
- KategoriBranschfond, läkemedel
- BasvalutaEUR
- UtdelningspolicyÅterinvesterande
- Faktablad
The Fund’s investment objective is to replicate the price and the performance, before fees and expenses, of an index that provides exposure to the performance of a representative portfolio of companies involved in the genomic healthcare and electronic healthcare industries.
Relaterade ETF:er
Nyheter
Orderdjup
Exponering
Fördelning
- Aktier100%
Kunder har även besökt
Forum
Allmän information
- Årlig avgift0,35%
- TillgångsklassAktier
- KategoriBranschfond, läkemedel
- BasvalutaEUR
- UtdelningspolicyÅterinvesterande
- Faktablad
The Fund’s investment objective is to replicate the price and the performance, before fees and expenses, of an index that provides exposure to the performance of a representative portfolio of companies involved in the genomic healthcare and electronic healthcare industries.
Relaterade ETF:er
Nyheter
Forum
Orderdjup
Exponering
Fördelning
- Aktier100%
